Kodiak Sciences EBIT

Kodiak Sciences (KOD) currently reports a EBIT of $-260M as of June 2026. That compares with $-210M in the prior-year period — down 25.0% year over year. That is below the Healthcare sector average of $22B. Use the charts on this page to explore Kodiak Sciences's EBIT history and peer comparisons.

Kodiak Sciences's EBIT decreased from $-210M to $-260M — a 25.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Kodiak Sciences's EBIT of $-260M is lower than the Healthcare sector average of $22B. That is roughly 101.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Kodiak Sciences reported $-260M in EBIT as of June 2026. That compares with $-210M in the prior-year period — down 25.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-260M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $22B. From there, open related valuation or income-statement pages for Kodiak Sciences, and consider following KOD for alerts when major investors trade the stock.